Filing Details

Accession Number:
0001209191-22-028684
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-12 20:15:20
Reporting Period:
2022-05-11
Accepted Time:
2022-05-12 20:15:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642545 Shockwave Medical Inc. SWAV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404227 Evan Douglas Godshall C/O Shockwave Medical, Inc.
5403 Betsy Ross Drive
Santa Clara CA 95054
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-11 15,000 $3.42 157,926 No 4 M Direct
Common Stock Disposition 2022-05-11 300 $134.28 157,626 No 4 S Direct
Common Stock Disposition 2022-05-11 1,523 $136.09 156,103 No 4 S Direct
Common Stock Disposition 2022-05-11 1,538 $136.84 154,565 No 4 S Direct
Common Stock Disposition 2022-05-11 1,239 $137.62 153,326 No 4 S Direct
Common Stock Disposition 2022-05-11 1,300 $139.00 152,026 No 4 S Direct
Common Stock Disposition 2022-05-11 3,100 $140.03 148,926 No 4 S Direct
Common Stock Disposition 2022-05-11 900 $140.84 148,026 No 4 S Direct
Common Stock Disposition 2022-05-11 300 $142.10 147,726 No 4 S Direct
Common Stock Disposition 2022-05-11 500 $142.87 147,226 No 4 S Direct
Common Stock Disposition 2022-05-11 1,500 $145.02 145,726 No 4 S Direct
Common Stock Disposition 2022-05-11 1,400 $146.12 144,326 No 4 S Direct
Common Stock Disposition 2022-05-11 700 $147.15 143,626 No 4 S Direct
Common Stock Disposition 2022-05-11 700 $148.30 142,926 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-05-11 15,000 $0.00 15,000 $3.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
469,799 2027-05-09 No 4 M Direct
Footnotes
  1. All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022.
  2. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $134.03 to $134.77. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  3. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $135.35 to $136.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  4. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $136.35 to $137.32. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  5. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $137.38 to $138.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  6. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $138.48 to $139.45. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  7. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $139.55 to $140.49. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  8. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.61 to $141.45. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  9. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $141.68 to $142.45 The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  10. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $142.68 to $142.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  11. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $144.48 to $145.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  12. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $145.55 to $146.54. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  13. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $146.79 to $147.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  14. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $147.82 to $148.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  15. Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.